Author

Silvio Wuschko

Observed name: S Wuschko

Institution: Octapharma (Austria)

Observed institution: Octapharma (Austria)

OpenAlex ID: A5079079227

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

2004 · Jürgen Soutschek, Akin Akinc, et al. · Nature · 2,184

Toxicological testing of allogeneic secretome derived from peripheral mononuclear cells (APOSEC): a novel cell-free therapeutic agent in skin disease

2019 · Silvio Wuschko, Alfred Gugerell, et al. · Scientific Reports · 21

Cytokine dynamics following joint injury in hemophilia A mice

2026 · O Oleshko, L Monica, et al. · Hämostaseologie

Characterization of a factor VIII/immunoglobulin heavy chain μ double-knockout mouse model of hemophilia A for long-term exposure to factor VIII proteins

2025 · Lara Monica, Olga Oleshko, et al. · Research and Practice in Thrombosis and Haemostasis

Impact of secondary FVIII prophylaxis on joint bleeding and arthropathy in a Hemophilia A mouse model lacking inhibitor response

2025 · Lara Monica, Joyce Kimenai, et al. · Blood

Works count: 5

Citation count: 2,205

H-index: 2

I10-index: 2